Startups

Prime Medicine, Inc.

Prime Medicine develops prime-editing therapies designed to precisely correct disease-causing genetic mutations.

Team

No team members on record yet.

$200M2021-07-13	ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Casdin Capital, Cormorant Asset Management, Moore Strategic Ventures, PSP Investments, Redmile Group, Samsara BioCapital, T. Rowe Price Associates
$—Unknown date	ARCH Venture Partners, Casdin Capital, F-Prime Capital, T. Rowe Price, Cormorant Asset Management, Public Sector Pension Investment Board
$—Unknown date	ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Samsara BioCapital